Godrej Agrovet Q1 FY27: Profit falls 14%, margin slips

Key takeaway from the June quarter

Godrej Agrovet reported weaker profitability in the first quarter of FY27 even as consolidated sales rose year-on-year. The company said revenue growth was offset by pressure on operating performance across select business segments. The earnings update covers the quarter ended June 30, 2026, and was approved at a Board meeting held on August 5, 2026.

The headline numbers show a typical mix for agri-linked businesses in a volatile cost environment: top-line growth, but softer margins. EBITDA declined and the EBITDA margin contracted sharply versus the year-ago quarter. Management flagged cost headwinds and weather-related issues affecting some parts of the portfolio.

Q1 FY27 profit drops as EBITDA contracts

On a consolidated basis, net profit for Q1 FY27 came in at ₹128.3 crore, down 13.8% from ₹149 crore in Q1 FY26. The company’s EBITDA declined 10.9% year-on-year to ₹240.1 crore from ₹269.6 crore in the year-ago quarter.

The margin picture explains most of the profit decline. EBITDA margin narrowed to 8.41% in Q1 FY27 from 10.32% in Q1 FY26. With profitability under pressure, the quarter highlights how quickly cost and mix changes can impact earnings even when revenue continues to expand.

Revenue growth remains intact

Godrej Agrovet reported consolidated sales of ₹2,852 crore in Q1 FY27, up from ₹2,603 crore in Q1 FY26. This reflected year-on-year growth in the top line, which the company described as double-digit sales growth on a consolidated basis.

However, the benefit of higher sales did not translate into higher operating profit. The company noted that cost headwinds across select segments weighed on profitability during the period.

Profit before tax (excluding non-recurring items) also weakens

Profit before tax (excluding non-recurring items) declined to ₹172 crore in Q1 FY27 from ₹188 crore in Q1 FY26. The company also clarified that this profit before tax measure excludes share of profit from joint ventures.

This movement is consistent with the EBITDA decline and margin contraction. Even with higher sales, lower profitability at the operating level reduced the buffer available for the rest of the profit and loss account.

Segment picture: Animal Nutrition strong on volumes

Godrej Agrovet’s Animal Nutrition business in India posted strong volume momentum. The company reported approximately 15% year-on-year growth in cattle feed volumes. It also reported around 36% year-on-year improvement in underlying segment results for Animal Nutrition.

The Animal Nutrition performance stands out because it indicates demand strength and a better segment outcome despite the broader margin pressure at the consolidated level. The company’s narrative suggests that cost and performance pressures were more pronounced in other parts of the business mix.

Dairy business: higher value-added product mix

In the Dairy business, Godrej Agrovet reported an improvement in value-added product salience, rising from 42% to 49%. The company also reported that Creamline Dairy recorded revenue growth of 11% and volume growth of 8%.

These metrics point to a shift toward higher-value products and improved mix within dairy operations. Still, the consolidated margin decline indicates that the gains in mix were not enough to offset cost headwinds across the overall portfolio.

Mixed outcomes across other businesses

Godrej Agrovet reported positive trends in a few other verticals. The Oil Palm business recorded EBIT growth of 14% and volume growth of 9%. In processed foods, Godrej Foods posted Yummiez volume growth of 22%.

But not all segments moved in the same direction. The Crop Care business saw de-growth of around 17% due to weather delays. Astec LifeSciences continued to remain at break-even at the EBITDA level, as disclosed in the segment snapshot.

What the board approval signals

The company said it announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, following the Board of Directors meeting held on August 5, 2026. It described the quarter as one where resilient top-line growth in key segments came alongside transient cost pressures and weather-related headwinds.

While the release does not provide a detailed cost breakdown, the combination of lower EBITDA and a meaningful margin contraction indicates that inflationary inputs, pricing, or product mix likely tightened profitability during the quarter.

Key numbers table: Q1 FY27 vs Q1 FY26

*Profit before tax excludes share of profit from joint ventures and non-recurring items, as stated by the company.

Market impact: what investors should track next

For investors, the key signal from Q1 FY27 is the gap between sales growth and operating profitability. The quarter shows that margin sensitivity remains high, especially when certain segments face weather-related disruption or cost pressure.

Operationally, the most important monitorables from the disclosed data are whether Animal Nutrition’s strong volume growth sustains, whether the dairy mix shift continues beyond the reported salience increase from 42% to 49%, and whether Crop Care normalises after the weather delay-led de-growth of around 17%.

Conclusion

Godrej Agrovet’s Q1 FY27 results show higher sales but weaker profitability, with net profit down 13.8% and EBITDA margin falling to 8.41%. The company pointed to cost headwinds and weather-related challenges, even as select segments such as Animal Nutrition and Oil Palm posted growth. The next set of results will be watched for signs that margin pressure is easing and that impacted segments are recovering from transient disruptions.